The patent covers intermediate compounds and processes for the preparation of Fingolimod Ness Ziona, Israel, February 18, 2014 —- Mapi Pharma Ltd. (“Mapi” or the “Company”), a developer of high-barrier to entry and high value-added generic drugs that include... 